Astria Therapeutics (ATXS) Assets: 2017-2019
Historic Assets for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $43.8 million.
- Astria Therapeutics' Assets fell 1.94% to $43.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $43.8 million, marking a year-over-year decrease of 1.94%. This contributed to the annual value of $39.2 million for FY2018, which is 118.86% up from last year.
- According to the latest figures from Q3 2019, Astria Therapeutics' Assets is $43.8 million, which was down 9.67% from $48.5 million recorded in Q2 2019.
- Astria Therapeutics' Assets' 5-year high stood at $54.5 million during Q1 2019, with a 5-year trough of $17.9 million in Q4 2017.
- Moreover, its 3-year median value for Assets was $39.2 million (2018), whereas its average is $36.8 million.
- In the last 5 years, Astria Therapeutics' Assets crashed by 45.28% in 2018 and then surged by 197.96% in 2019.
- Quarterly analysis of 3 years shows Astria Therapeutics' Assets stood at $17.9 million in 2017, then soared by 118.86% to $39.2 million in 2018, then decreased by 1.94% to $43.8 million in 2019.
- Its Assets was $43.8 million in Q3 2019, compared to $48.5 million in Q2 2019 and $54.5 million in Q1 2019.